Alfimeprase: Pharmacology of a Novel Fibrinolytic Metalloproteinase for Thrombolysis

Publisher： Karger

E-ISSN： 1424-8840|31|3-6|141-147

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.31, Iss.3-6, 2002-03, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Clinical and Clinical Characterization of a Novel Acting Thrombolytic: Alfimeprase

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 4-5, 2006-05 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

First proof of pharmacology in humans of a novel glucagon receptor antisense drug

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 298-306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of the Fibrinolytic Components in Endometriosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

The Fibrinolytic System and Thrombotic Tendency

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 425-429

Karger

Access to resources Recommend Favorite